These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes. Loebstein R; Dushinat M; Vesterman-Landes J; Silverman B; Friedman N; Katzir I; Kurnik D; Lomnicky Y; Kokia E; Halkin H J Clin Pharmacol; 2011 Feb; 51(2):173-80. PubMed ID: 20484611 [TBL] [Abstract][Full Text] [Related]
45. Metformin in adolescents with polycystic ovary syndrome: opposed. Trent M J Pediatr Adolesc Gynecol; 2002 Apr; 15(2):111-4. PubMed ID: 12066790 [No Abstract] [Full Text] [Related]
46. [A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults]. Plauchu M; Thevenon P Lyon Med; 1968 Oct; 220(42):953-63. PubMed ID: 5742623 [No Abstract] [Full Text] [Related]
47. Homocysteine and cardiovascular risk in patients with diabetes mellitus. Yeromenko Y; Lavie L; Levy Y Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):108-16. PubMed ID: 11434188 [TBL] [Abstract][Full Text] [Related]
48. [Metformin--sensible or nonsensible change of treatment in the post-operative phase]. Jost U; Böhrer H Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Aug; 37(8):461-2. PubMed ID: 12165914 [No Abstract] [Full Text] [Related]
49. Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment. Panossian Z; Drury PL; Cundy T Diabetologia; 2012 Jan; 55(1):267-9. PubMed ID: 22072157 [No Abstract] [Full Text] [Related]
50. [Treatment of diabetes mellitus with the E.R. 105 oral preparation]. Domingo Gutiérrez AJ Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090 [No Abstract] [Full Text] [Related]
51. Metformin and pancreatic cancer: a clue requiring investigation. Pollak M Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829 [TBL] [Abstract][Full Text] [Related]
52. A patient request for some "deprescribing". Unwin D; Tobin S BMJ; 2015 Aug; 351():h4023. PubMed ID: 26239952 [No Abstract] [Full Text] [Related]
53. Metformin stinks, literally. Pelletier AL; Butler AM; Gillies RA; May JR Ann Intern Med; 2010 Feb; 152(4):267-8. PubMed ID: 20157150 [No Abstract] [Full Text] [Related]
55. Diabetes drugs a problem in heart failure. Harv Heart Lett; 2003 Sep; 14(1):7. PubMed ID: 14505978 [No Abstract] [Full Text] [Related]
56. Metformin does not improve survival of cholangiocarcinoma patients with diabetes. Yang Z; Zhang X; Roberts RO; Roberts LR; Chaiteerakij R Hepatology; 2016 Feb; 63(2):667-8. PubMed ID: 25833233 [No Abstract] [Full Text] [Related]
57. [Anti-oncogenic effect of metformin]. Noto H Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176 [No Abstract] [Full Text] [Related]
58. A pharmacist's perspective on metformin use and cancer outcomes. Ceacareanu AC J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081 [No Abstract] [Full Text] [Related]
59. Gastrointestinal Conditions in the Obese Patient. Taylor SA; Himes R; Hastings E; Garland B Adolesc Med State Art Rev; 2016; 27(1):93-108. PubMed ID: 27363235 [TBL] [Abstract][Full Text] [Related]